Infinity To Present At 37th Annual J.P. Morgan Healthcare Conference

Friday, January 4, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

CAMBRIDGE, Mass., Jan. 3, 2019 /PRNewswire/ --áInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting

at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019, at 9:30 a.m. PST (12:30 p.m. EST) in San
Francisco, CA.
A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:Stephanie Ascher, Stern Investor Relations, Inc.212-362-1200 or Stephanie@sternir.com

á

á

á

Cision View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-37th-annual-jp-morgan-healthcare-conference-300772638.html

SOURCE Infinity Pharmaceuticals, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store